# DOW LAO Blood Bank – FDA Inspection, Jun 28, 2018

Source: https://www.keypedia.com/records/fda_inspections/dow-lao-blood-bank/3c470ece-5fd9-4027-9c48-35187d097539
Source feed: FDA_Inspections

> FDA inspection 1062223 of DOW LAO Blood Bank, June 28, 2018. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062223
- Company Name: DOW LAO Blood Bank
- Inspection Date: 2018-06-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1211182 - 2023-07-12
- FDA Inspection 967541 - 2016-04-07
- FDA Inspection 871324 - 2014-03-25
- FDA Inspection 786396 - 2012-06-14
- FDA Inspection 681928 - 2010-09-23

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/juanelma-h-palmer/db3e79b5-d2d4-46d8-a075-4674dbc8c3d0)

Company: https://www.keypedia.com/companies/dow-lao-blood-bank/52623460-27cd-456d-a1a6-37c211af6ebb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d